Oncolytics Biotech, Inc. (Nasdaq: ONCY) announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045). The principal investigator is Tanios Bekaii-Saab, MD, associate professor and gastrointestinal oncology section chief at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The trial is sponsored by the U.S. National Cancer Institute (NCI) through a clinical trials agreement between the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis and Oncolytics. Oncolytics is providing clinical supplies of REOLYSIN for the study. Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) weekly performance is 26.72%. On last trading day company shares ended up $1.66. Analysts mean target price for the company is $7.23. Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) distance from 50-day simple moving average is 23.64%.
On June 16,2014 H.C. Wainwright initiated coverage on EDAP TMS S.A. (NASDAQ:EDAP) with a Buy rating and a price target of $6.00. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) shares fell -6.70% in last trading session and ended the day on $5.43. EDAP Gross Margin is 41.20% and its return on assets is -1.30%. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) quarterly performance is 82.21%.
On June 18,2014 Exeter Resource Corporation (NYSE MKT:XRA)(TSX:XRC)(FRANKFURT:EXB) (“Exeter” or the “Company”) announced the voting results from its annual general and special meeting of shareholders (Annual Meeting) held on Wednesday June 18, 2014, in accordance with Toronto Stock Exchange requirements. A total of 46,865,441 common shares representing 53.01% of Exeter’s issued and outstanding common shares were voted in connection with the election of directors at the Annual Meeting. Exeter Resource Corp. (NYSEMKT:XRA) shares moved up 6.38% in last trading session and was closed at $0.830, while trading in range of $0.77-$0.87. Exeter Resource Corp. (NYSEMKT:XRA) year to date performance is 56.57%.
—–China Information Technology, Inc. – Ordinary Shares (NASDAQ:CNIT) ended the last trading day at $5.25. Company weekly volatility is calculated as 15.00%. China Information Technology, Inc. – Ordinary Shares (NASDAQ:CNIT) showed a positive weekly performance of 24.70%.
On June 11,2014 Revolution Lighting Technologies, Inc. (NASDAQ:RVLT) (“Revolution Lighting”), a leader in advanced LED lighting solutions, announced that SL Green Realty Corp. (NYSE: SLG), New York City’s largest commercial property owner, has selected its Seesmart brand LED tube lamps for an LED retrofit at nine commercial office properties to save $370,000 annually in operating expenses.Revolution Lighting Technologies Inc (NASDAQ:RVLT) net profit margin is -99.20% and weekly performance is 11.74%. On last trading day company shares ended up $2.57. Analysts mean target price for the company is $3.00. Revolution Lighting Technologies Inc (NASDAQ:RVLT) distance from 50-day simple moving average is 6.71%.
Leave a Reply